Well, the Patent Act schedules of countries and drugs were never part of the WTO decision. That was something that we made up here in Canada; it wasn't required. It was never part of the original agreement internationally; we just invented that here.
When we invented that here, one of the things we raised was that there would be active lobbying to keep certain drugs and certain countries off the list. That happened with Bayer: they actually started to lobby to keep a drug off the list.
So the schedules become a big problem in many respects, because we just made up the rules and the countries and the drugs to put on a list when we didn't have to require that. Some of the testimony we've heard over this period of time is that the lists and schedules were not necessary.
In the spirit of compromise, I've agreed to maintain the status quo or, if Mr. Garneau has a better system here, to support that. That's the reason I will continue to accept the fact that if we have countries and schedules, it's because there seems to be a greater want for this made-up system that we created back in 2004.
However, I never believed it was necessary to begin with and it certainly created real problems that made headlines here in Canada. As I mentioned, there was an argument that companies would lobby the ministers and other people to keep their drugs off the list, and it turned out that Bayer was actually doing that as we had hearings here in Ottawa.